- Japan: The Company concentrated on enhancing sales activities which match each market; the acute care hospital market, the small and mid-sized hospital market, and the clinic market. The Company also focused on its consumables and services business as well as strengthening its marketing and service capabilities, creating customer value which contributed to improving medical safety, patient outcomes, and operating efficiency. As a result of these measures, domestic sales increased. Sales of AEDs showed strong growth in the PAD (public access defibrillation) market. Sales in the university and clinic markets also increased favorably. Sales in the private hospital market remained flat and sales in the public hospital market decreased.
- International: Sales in all regions increased. Overseas sales achieved double-digit growth on a local currency basis excluding the currency effect and the impact of the consolidation of Ad-Tech. Sales in North America showed double-digit growth, posting a significant increase in sales of neurology products including Ad-Tech as well as favorable sales of Treatment Equipment such as ventilators and AEDs. Sales of Patient Monitors remained flat on a local currency basis and decreased on a yen basis due to yen appreciation. Sales in Latin America increased, mainly in Brazil. Sales in Europe increased favorably, especially in Turkey, Italy, France, and the U.K. Sales in Asia & Other achieved double-digit growth, as sales in Thailand and Vietnam showed strong growth and sales in China also increased.
（Years ended/ending March 31, million yen）
|
2025 1Q |
2026 1Q |
YoY (%) |
|
|
Domestic Sales |
29,493 |
30,686 |
4.0 |
|
Overseas Sales (Overseas Sales Ratio) |
16,734 (36.2%） |
19,334 （38.7%） |
15.5 |
|
North America |
9,281 |
11,015 |
18.7 |
|
Latin America |
993 |
1,026 |
3.3 |
|
Europe |
2,658 |
2,919 |
9.8 |
|
Asia & Other |
3,799 |
4,373 |
15.1 |
